Parkinson's disease in China: care options, technology and a guide for international patients

From precise diagnosis and medication adjustments to deep brain stimulation (DBS), focused ultrasound and cell therapy, this guide explains the care pathway for patients travelling to China.

Prepared and published by SinoCareHub Huayitong International Medical. This article provides general medical information and does not replace a doctor's diagnosis.

1. There is more to Parkinson's than hand tremor

Parkinson's disease (PD) is the second most common neurodegenerative disease. Dopamine-producing neurons in an area of the brain called the substantia nigra are gradually lost, leading to a shortage of dopamine. The main signs are tremor, stiffness, slow movement and unsteady walking. Non-motor symptoms such as reduced sense of smell, constipation, sleep problems, depression and anxiety are also common. Symptoms often start on one side and progress slowly.

2. Why getting the diagnosis right matters

Many international patients wonder whether they have Parkinson's. Clinicians need to distinguish it from conditions such as essential tremor, multiple system atrophy and progressive supranuclear palsy. Major Chinese centres combine clinical experience with medical history, motor assessments, brain imaging, dopamine transporter (DAT) imaging, genetic testing and biomarkers to assess and classify the condition.

3. The stage of disease affects treatment options

4. Parkinson's cannot be cured, but symptoms can be managed over the long term

Current medicine cannot reverse the loss of neurons. Standard care aims to extend the years a person can live with good quality of life, reduce complications and preserve mobility and independence. The Chinese approach combines medicines, surgery, rehabilitation, psychological support and nursing care.

5. Earlier standard care can help avoid inappropriate medicines or poorly timed procedures

Care is often delayed when people take Parkinson's medication without a confirmed diagnosis, or put off DBS even after they are eligible. For many patients coming to China, the first step is a specialist review of the diagnosis and disease stage.

1. Using objective markers alongside clinical judgement

Neurological examination and the MDS-UPDRS rating scale

Brain DAT-PET or SPECT imaging to help distinguish Parkinson's disease from parkinsonian syndromes

Additional tests such as ultrasound of the substantia nigra and cardiac MIBG imaging

Genetic testing and counselling for genes including LRRK2, PARKIN and PINK1

Research on biomarkers such as the alpha-synuclein seed amplification assay (SAA) in cerebrospinal fluid, at some centres

A suspected diagnosis made abroad can be reviewed and further classified in China. The team can then assess whether to continue medication, consider early surgery or explore clinical research.

2. A range of options from medication to neuromodulation, ablation and cell therapy

China has a tiered treatment pathway:

Medication titration with levodopa, dopamine receptor agonists, MAO-B inhibitors, COMT inhibitors and other drugs

Deep brain stimulation (DBS), sometimes called a brain pacemaker: the preferred surgical approach when medication becomes less effective or complications are significant

MR-guided focused ultrasound (MRgFUS): uses heat to irreversibly ablate a specific brain target without opening the skull and may suit some carefully selected patients whose main symptom is tremor

Cell and gene therapies: clinical research approaches include autologous stem cells, iNSC-DAP and transplantation of neural stem cells via the nasal mucosa

3. Equipment and surgical experience

Beijing Tiantan Hospital performed China's first DBS procedure for Parkinson's disease in 1998. China now has more than 20 years of experience. Published reports put the annual volume on the order of 10,000 procedures, with more than 300 treatment centres. This scale supports standard surgical pathways, established complication management and teams experienced in programming after surgery.

4. How diagnosis, assessment and treatment planning fit together

Patients can ask centres such as Peking Union, Tiantan, Xuanwu, Chinese PLA General Hospital, Huashan and West China Hospital about the process below. Confirm scheduling and the language of written reports with the hospital.

After arrival, the doctor may order neurological assessment, imaging, DAT imaging, laboratory tests and cognitive or psychological assessment as needed.

A multidisciplinary review may be arranged to assess treatment options and surgical feasibility.

If DBS is appropriate, the hospital schedules the preoperative assessment, target planning and stereotactic procedure.

Programming after surgery: remote programming can reduce the need for repeated hospital visits.

5. What to compare when estimating treatment costs

SinoCareHub can help patients request a written estimate. Final charges depend on the hospital's assessment.

1. Medication: adjust doses to the individual

The fifth edition of the Chinese Parkinson's Disease Treatment Guidelines takes a comprehensive, multidisciplinary approach throughout the course of care. Doctors tailor treatment by age, symptoms, cognitive status, coexisting conditions and response to medicines. For international patients, the team often first reviews their medication history, assesses the drug holiday and checks for wearing off or dyskinesia, rather than immediately increasing the dose.

2. Deep brain stimulation (DBS) for patients at middle or advanced stages

3. MR-guided focused ultrasound (MRgFUS): a non-invasive option

MR-guided focused ultrasound uses heat to ablate a specific brain target without opening the skull. The resulting tissue change is irreversible. It may be considered for selected patients with tremor-dominant Parkinson's disease. It requires no open surgery or implant. Fewer patients are eligible and long-term data are still being collected. A movement disorders team and imaging specialists must assess suitability together.

4. Cell and gene therapies under investigation

A Peking Union Medical College Hospital team is conducting a phase I study of human neural stem cell transplantation via the nasal mucosa for Parkinson's disease, exploring a non-invasive route.

Xuanwu Hospital, Capital Medical University, is studying iNSC-DAP, dopaminergic neural progenitor cells derived from induced neural stem cells, in a global first or early clinical research.

Huashan Hospital and other institutions are pursuing alpha-synuclein immunotherapy, biomarker and disease-modification research.

Most of these approaches are in early or phase I/II clinical research. They involve eligibility criteria, follow-up periods and uncertain risks, and will not suit every international patient. Be wary of claims that an injection can cure Parkinson's.

The Hainan Boao Lecheng International Medical Tourism Pilot Zone has a special pathway for urgently needed imported medicines and devices. A designated medical institution must apply to use an eligible product already marketed abroad.

Ask the hospital to verify the specific DBS device or other product and the scope of its approval.

The special pathway does not establish access to cell or gene therapy. Confirm regulatory and research status separately.

Facilities such as Ruijin Hainan Hospital and West China Lecheng Hospital can be asked about specific programmes, assessment and admission arrangements.

Patients interested in trials can ask the study centre about recruitment and eligibility.

Lecheng provides a special route for early access and complements leading hospitals elsewhere in China. SinoCareHub can help patients consider whether to seek standard care in Beijing, Shanghai or Chengdu first, or ask about the Lecheng pathway.

Peking Union Medical College Hospital

Wang Renzhi: neurosurgery, cell therapy and movement disorder surgery

Bao Xinjie: neurosurgery and clinical stem cell research

Wan Xinhua: neurology, diagnosis and treatment of movement disorders

Wang Han: neurology, Parkinson's disease and movement disorders

Xuanwu Hospital, Capital Medical University

Zhao Guoguang: neurosurgery, neuromodulation and cell therapy

Chen Biao: neurology, Parkinson's disease and movement disorders

Chen Zhiguo: cell therapy centre, neural stem cell research

Lu Jie: radiology and nuclear medicine, imaging assessment

Beijing Tiantan Hospital

Zhang Jianguo: neurosurgery, DBS and neuromodulation for movement disorders, one of China's DBS pioneers

Feng Tao: neurology, diagnosis and treatment of Parkinson's disease and movement disorders

Chinese PLA General Hospital

Mao Zhiqi: neurosurgery, deep brain stimulation and neuromodulation

Xu Xin: neurosurgery, postoperative DBS programming and movement disorders

Huashan Hospital, Fudan University

Wang Jian: neurology, Parkinson's disease, movement disorders and biomarker research

Chen Liang: neurosurgery, functional neurosurgery and DBS

Wu Jianjun: neurology, movement disorders and DBS assessment

Zuo Chuantao: nuclear medicine, brain DAT imaging and molecular imaging

West China Hospital, Sichuan University

Shang Huifang: neurology, Parkinson's disease and movement disorders, and DBS assessment

Li Peng: neurosurgery, DBS implantation and neuromodulation programming

Notice: The hospital and specialists make the final assessment on appointment schedules, who can be seen, eligibility for surgery and admission to clinical research. SinoCareHub helps match patients with services and coordinates requests. It cannot guarantee a particular specialist.

Step 1. Review records before booking flights

Send the diagnosis, medication list, DICOM imaging disc, past treatment records and videos of symptoms. We assess whether the diagnosis needs to be revisited, DBS may be suitable or a newer approach in Lecheng could be explored.

Step 2. Match care options and arrange a remote consultation (required)

We match you with hospitals and specialists based on age, disease duration, symptoms, cognitive status and budget. A video consultation can be arranged for a preliminary written opinion.

Step 3. Submit records for preliminary hospital review

We help organise bilingual Chinese and English records, translate reports, submit the request to the hospital or department and follow up. The hospital and doctors decide whether to accept the case and what additional tests are needed.

Step 4. Arrange a medical invitation and visa documents

After the hospital has received and confirmed your request, we help prepare the invitation letter, written cost estimate and other supporting documents, and guide you through the medical visa application.

Step 5. Arrive for treatment and receive support at appointments

Airport pickup and arrangements for accommodation and transport

Professional medical interpreting and accompaniment throughout

Help completing assessments, tests, treatment and the discharge summary

Coordination of postoperative programming, rehabilitation and follow-up

Step 6. Cross-border follow-up after returning home

We organise discharge documents in Chinese and English, programming records and a schedule for check-ups. We also help arrange remote follow-up so you can stay in touch with your treatment team from home.

SinoCareHub is an international medical services brand operated by Huayitong International Medical Services (Hainan) Co., Ltd. For patients with Parkinson's, we coordinate the process from diagnosis through follow-up at home. We do not provide medical advice:

Medical notice: SinoCareHub provides information and coordinates medical travel in China for international patients. It does not give individual diagnosis or treatment advice. The hospital and treating doctors decide whether to accept the case and determine appointments, admission and treatment.

I was diagnosed with Parkinson's abroad. Will I need all my tests again in China? Not necessarily. The team usually reviews the diagnosis and may add DAT imaging, other scans or rating scales to assess whether DBS or clinical research is appropriate.

Can I receive care if I do not speak Chinese? Yes. SinoCareHub provides professional medical interpreting and accompaniment throughout.

How soon can treatment start? Assessment timing depends on the records, required tests and hospital schedule. DBS scheduling depends on the preoperative assessment.

Can I request a particular specialist? We prioritise your preference, but the hospital manages schedules and admission and we cannot guarantee either.

Is focused ultrasound or DBS better? There is no universally better option. The choice depends on symptoms, age, cognition, coexisting conditions and the state of the target organ. It requires multidisciplinary assessment.

Can cell therapy cure Parkinson's disease? It is still at the clinical research stage and there is no promise of a cure. Eligibility for a study requires careful assessment.

Parkinson's requires long-term management, and patients have options. In China, the pathway can include precise diagnosis, individually adjusted medication, deep brain stimulation, focused ultrasound and cell therapy, with a clear sequence of care, a range of technologies and costs that can be managed.

You do not have to go through it alone. Send us your records so a specialist team can assess whether the next step should be adjusting medication, considering surgery or asking about clinical research. You can focus on your care while SinoCareHub coordinates the rest.

Official website: https://sinocarehub.com

Service provider: Huayitong International Medical Services (Hainan) Co., Ltd.